TriCo Bancshares Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TriCo Bancshares

Kahn Swick & Foti, led by former Louisiana Attorney General Charles Foti, is investigating First Hawaiian's proposed acquisition of TriCo Bancshares. TriCo shareholders would receive 2.095 First Hawaiian shares for each TriCo share under the transaction. The investigation introduces potential shareholder-litigation and deal-execution risk, though the release provides no allegation, financial damages estimate, or change to the transaction terms.

Analysis

The legal-investigation notice is not, by itself, evidence of a transaction defect; these announcements are routinely issued after public M&A terms and rarely alter consideration absent a credible competing bid, fiduciary-process discovery, or a material deterioration in the acquirer's currency. The relevant market signal is therefore the TCBK/FHB exchange-ratio spread versus the implied 2.095x consideration, not the press-release headline. A widening spread without incremental deal-specific disclosures would more likely reflect closing-duration, regulatory, or FHB-share-volatility risk than litigation probability.

For FHB, an all-stock structure makes accretion and capital math sensitive to its own valuation through closing. If FHB shares weaken, TCBK holders absorb that drawdown directly and the target may trade at a structurally larger discount; conversely, FHB strength can create a self-reinforcing narrowing of the merger spread. Over the next 1-3 months, monitor merger-proxy disclosure for pro forma CET1, deposit attrition assumptions, credit marks, cost-save timing, and regulatory conditions; these variables matter materially more than shareholder-law-firm activity.

The non-obvious risk is execution across two distinct regional banking franchises: anticipated cost synergies can be offset by deposit migration and above-plan systems conversion costs, while any renewed pressure in commercial real estate or uninsured-deposit funding would raise the value of standalone balance-sheet flexibility. A credible higher bidder is possible but should not be underwritten without evidence that TCBK's standalone valuation or deposit franchise exceeds the exchange ratio materially. Thesis is falsified by a definitive proxy showing weak pro forma capital, elevated credit marks, extended regulatory timing, or a sustained deterioration in FHB that widens the implied consideration discount.

Key Decisions for Investors

• No standalone trade on the investigation notice; treat it as low-information event risk unless a plaintiff filing, injunction request, revised consideration, or competing indication emerges.
• For merger-arbitrage exposure, monitor the implied TCBK value at 2.095x FHB and initiate only if the annualized gross spread compensates for an assumed 6-9 month closing window and FHB borrow/liquidity are confirmed. Structure long TCBK / short 2.095 FHB shares to isolate deal-completion risk from acquirer-equity beta.
• Use a deal-break alert rather than a directional FHB short: reassess the pair if proxy disclosures show pro forma capital below management targets, cost saves materially below underwriting, or regulatory timing beyond nine months.
• For existing TCBK holders unwilling to assume FHB equity exposure, reduce position size into spread compression; the exchange ratio leaves holders exposed to FHB price declines until close, while litigation-driven upside is typically limited absent a superior bid.